Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain - Wikidata - awgldk - TriplyDB

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

http://www.wikidata.org/entity/Q37365638

about

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play An integrated strategy for evaluation of metabolic and oxidative defects in neurodegenerative illness using magnetic resonance techniques.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementias Magnetic resonance imaging and magnetic resonance spectroscopy in dementias [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology.Various MRS application tools for Alzheimer disease and mild cognitive impairment.Imaging of Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.High-field magnetic resonance imaging of brain iron: birth of a biomarker?Common processing of in vivo MR spectra.Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.Method to correlate 1H MRSI and 18FDG-PET.In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging.1H magnetic resonance spectroscopy in dementia.Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging 1H MR spectroscopy in common dementias 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases.Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging.Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy.Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging.Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.

P2860

Q24594531-96726C68-1BBE-4FEA-8A81-EB0E64F58E74 Q30586618-1A9DD0F0-2683-4836-AC2C-72C20639D856 Q30630699-37A23FD9-757B-4FB7-8BAB-299F06450A2F Q30660402-3B39BB28-A446-46F1-8E0A-485DCCE5C317 Q30660816-4315BEB3-D331-4BE0-9E4F-9CBC53BB0C46 Q30666607-2B87EF63-40B3-4DE1-839C-3899694219D2 Q30712330-B104BA4B-3153-408B-8AB5-AF3E3874BFCC Q30803093-E8D187D2-B1EE-490B-ADDB-A348CB585ADE Q30815106-F6210E81-8DA8-4090-A590-97320D358BB4 Q30996805-35A88776-C314-483F-9B82-7036B7590EC3 Q33208658-4C423208-881D-4DF8-9BE3-F62EF08E7639 Q34285090-664A8D4B-D339-4B7C-8EE7-85DFE2F60C3B Q35572392-E0B6F207-FA9B-45FB-BDCB-AA2D528CA772 Q35781558-BFF48F35-8BCB-4566-8534-294AAD0DF9DE Q35933438-C08C5191-8D50-4D7A-91D1-9C8284100177 Q36012768-E56D085C-DE5C-42EB-B3B2-42A5DE6F1662 Q36532969-8C599EE5-40DF-482B-BA21-859246838564 Q37150637-47E2A4D1-4351-4D05-A14B-65FA78E3FD6C Q37322588-05FDCE26-E414-4F60-A24A-98A953B2378C Q37398605-F123E00B-7674-4DB4-A811-A0F334ED112C Q37398623-CDE9E1B8-ECF6-49AC-A379-F8307470F969 Q37407266-6BB74EC1-9190-4DCC-ABF5-8EDFFC2374FA Q37418999-1C63AD28-E842-436D-A29F-BF8B96636DE7 Q40285261-C2A363EF-67E6-4E12-B062-FF4331A4DD03 Q42655692-DB2BAD71-35F5-4067-9B21-E93067FC3106 Q43509689-9AC94201-8F70-43ED-9D4C-3AB8AE0C7F0D Q44065892-0A9BDE26-D918-4331-8020-F98A1474F9C7 Q44165239-699E20AF-3F51-4138-A864-18308C30C20E Q44169486-B56CE3C6-7A50-4E0C-A8E6-2AFDBEA1D2F3 Q44435570-A5E2790F-D67C-4A67-8E06-8F4064F55DA4 Q45300316-E691606D-C9F6-4D11-AC3E-9A8258B8C394 Q46793458-883A2FFC-23B9-4E7E-8B62-744E2594D985 Q48093526-5F91B976-E9A8-4121-8DF8-A87F18BB3455 Q48493964-206073C3-3429-48C1-ABAC-D6F410BD9FAA Q48670459-4BC9B327-EC7B-4D49-8956-491370B5D2CB

P2860

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

http://www.wikidata.org/entity/Q37365638

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

@en

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.

@nl

type

label

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

@en

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.

@nl

prefLabel

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

@en

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.

@nl

P1433

Q37365638-B5A70073-8D59-4487-B508-01502903D527

P1476

Q37365638-95CFC5DA-337A-4666-8666-AC8D35367148

P2093

Q37365638-1AB7842B-07DA-4874-98B2-BC29387C524F

Q37365638-2DFC67DF-602E-44D2-BA93-552497FF1903

Q37365638-70B30F87-0650-4D80-A18D-C93BBAE0FC79

Q37365638-A4D66106-7B46-47F6-ADCF-34C39C548DE5

Q37365638-AD8A80DB-A1DC-49C3-9172-C062F2BE8953

Q37365638-D6026487-EFBC-466B-90CE-E86C18D7290C

Q37365638-D696081C-1B1C-45BD-BE53-EF2D87415672

P2860

Q37365638-076D1145-C4C6-4A60-948E-EAE74653ACC1

Q37365638-0ECFB10C-8250-49C6-8BDD-5FDCE9F5D36F

Q37365638-11592248-0CE8-4406-A73E-E5533A67FA65

Q37365638-213BFE8F-4F9F-4BED-A894-1A3BB446B62E

Q37365638-24B2D008-093B-42BA-9F33-857E70C8F5B0

Q37365638-287DA2F2-849D-4731-B90F-B61375FCFA69

Q37365638-2F7A1653-8AFA-4576-B60C-4F6A0293E99B

Q37365638-355B60BE-DF16-4056-B10B-71D45F571BBB

Q37365638-38966A57-2D86-4AB8-8DBA-8696C60FEABF

Q37365638-3A3C81F6-A81F-4B6C-B20F-AA1FAAA10B79

P304

Q37365638-3B1DA8DF-6E2D-4BA6-8197-9F27BCC09F01

P31

Q37365638-398DC1AF-EBF4-4AE3-A197-76D0C81FCE92

P356

Q37365638-D4B026CE-A6D9-4854-B067-B25A39CD3261

P407

Q37365638-93779279-6E57-4A06-8B3C-6B0E0E36317B

P433

Q37365638-81F6F226-0891-4253-ACAD-245C26D81EFC

P478

Q37365638-3F2AD00F-6461-4FA2-8FE8-52D83E473F04

P577

Q37365638-B48F5A27-EDA0-4378-BAEB-E3122074CE94

P5875

Q37365638-C0044C20-E82E-42F4-878C-747DBA158EBF

P698

Q37365638-143ABDA2-5B84-4DF8-B26E-D314E8BA153D

P921

Q37365638-7FBD2B8D-63AB-44D4-BE6E-4599653E02E4

P932

Q37365638-79CB494D-2110-4229-A5F0-7414E1F37DC2

P356

RADIOLOGY.207.1.9530304

P1433

P1476

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

@en

P2093

D J Meyerhoff

http://www.w3.org/2001/XMLSchema#string

D L Amend

http://www.w3.org/2001/XMLSchema#string

D Norman

http://www.w3.org/2001/XMLSchema#string

G Fein

http://www.w3.org/2001/XMLSchema#string

J L Tanabe

http://www.w3.org/2001/XMLSchema#string

M W Weiner

http://www.w3.org/2001/XMLSchema#string

N Schuff

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease

Spectroscopic imaging display and analysis.

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease.

Short echo time proton MR spectroscopic imaging.

Multisection proton MR spectroscopic imaging of the brain.

Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging

Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging.

P304

91-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOLOGY.207.1.9530304

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

207

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51322746

http://www.w3.org/2001/XMLSchema#string

P698

9530304

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2753252

http://www.w3.org/2001/XMLSchema#string